Growth Metrics

Supernus Pharmaceuticals (SUPN) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Supernus Pharmaceuticals (SUPN) over the last 9 years, with Q3 2025 value amounting to $921000.0.

  • Supernus Pharmaceuticals' Amortizatization of Intangibles rose 19534.16% to $921000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 18377.79%. This contributed to the annual value of -$1.8 million for FY2024, which is 159426.23% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Amortizatization of Intangibles of $921000.0 as of Q3 2025, which was up 19534.16% from $32000.0 recorded in Q2 2025.
  • Supernus Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $1.7 million for Q1 2021, and its period low was -$2.1 million during Q3 2022.
  • Its 5-year average for Amortizatization of Intangibles is -$175000.0, with a median of -$18000.0 in 2022.
  • In the last 5 years, Supernus Pharmaceuticals' Amortizatization of Intangibles surged by 58514.06% in 2021 and then crashed by 393888.89% in 2023.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Amortizatization of Intangibles stood at -$1.3 million in 2021, then skyrocketed by 98.57% to -$18000.0 in 2022, then plummeted by 3938.89% to -$727000.0 in 2023, then soared by 192.71% to $674000.0 in 2024, then surged by 36.65% to $921000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $921000.0 for Q3 2025, versus $32000.0 for Q2 2025 and $1.1 million for Q1 2025.